|
WO2020237134A1
|
|
One step artificial antigen presenting cell-based vaccines
|
|
WO2020167899A1
|
|
System and method of tuberculosis therapy
|
|
WO2020132494A2
|
|
Methods for prognosing, diagnosing, and treating gastric cancer
|
|
WO2019191181A1
|
|
Peristaltic pump nerve block injection system and related methods
|
|
WO2019178217A1
|
|
Methods and compositions for treating, diagnosing, and prognosing cancer
|
|
WO2019178214A1
|
|
Methods and compositions related to methylation and recurrence in gastric cancer patients
|
|
WO2019178283A1
|
|
Methods and compositions for treating and prognosing colorectal cancer
|
|
WO2019178215A1
|
|
Methods and compositions for treating, prognosing, and diagnosing esophageal cancer
|
|
WO2018165532A1
|
|
Methods for diagnosing and treating gastric cancer using mirna expression
|
|
US2020140953A1
|
|
Methods for diagnosing, prognosing, and treating colorectal cancer using biomarker expression
|
|
WO2018068004A1
|
|
Classification of polyps using learned image analysis
|
|
CN109790585A
|
|
Method for diagnosing and treating cancer of the esophagus
|
|
US2018298386A1
|
|
Methods and compositions involving transmembrane and coiled-coil domains 3 (TM-CO3) in cancer
|
|
CN107074951A
|
|
Antagonism anti-OX 40 l antibodies and its application method
|
|
US2015368612A1
|
|
Methods and compositions for treating breast cancer with dendritic cell vaccines
|
|
EP3142691A1
|
|
Methods and compositions for treating autoimmune and inflammatory conditions
|
|
US2017067115A1
|
|
MiR-320e and colorectal cancer
|
|
AU2014240262A1
|
|
Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)
|
|
AU2014302082A1
|
|
Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis
|
|
AU2013358951A1
|
|
Triheptanoin for the treatment of glucose transporter 1 deficiency
|
